C. Vogelmeier (Marburg, Germany), P. Rottoli (Siena, Italy)
Pulmonary arterial hypertension (PAH) in patients with lung sarcoidosis (LS)
O. Baranova, V. Perlej, A. Speranskaja, S. Kabanova (Saint-Petersburg, Russian Federation)
|   |
Essential phospholipids in pulmonary sarcoidosis
H. Baradzina, V. Kamishnikov (Minsk, Belarus)
| |
The evaluation of oxygen-activating function of mononuclear phagocytes in sarcoidosis
N. D. Tahanovich, A. D. Tahanovich, I. L. Katovich, H. L. Baradina (Minsk, Belarus)
| |
Clinical, radiological, laboratory properties and diagnostic procedures in 179 patients with sarcoidosis
B. Ocakli, B. Uskul, H. Turker, S. Boga, C. Ulman, A. Kant, G. Acar (Istanbul, Turkey)
| |
Acute vasoresponsiveness to inhaled nitric oxide in sarcoidosis-associated pulmonary hypertension
N. Milman, C. B. Svendsen, C. M. Burton, M. Iversen, R. Videbaek, J. Carlsen (Copenhagen, Denmark)
| |
Childhood sarcoidosis in Denmark: long term follow-up of 46 children
N. Milman, C. B. Svendsen, A. L. Hoffmann (Copenhagen, Naestved, Denmark)
| |
Detection of Rickettsia in archival tissue samples from Danish patients with sarcoidosis
C. B. Svendsen, N. Milman, C. B. Andersen, K. A. Krogfelt (Copenhagen, Denmark)
| |
Sarcoidosis of pleura
P. Kukol, I. Jonner, P. Oravec, J. Havelkova, P. Janik (Vysne Hagy, Slovakia)
| |
The reflection of the ventilatory dysfunction by the bronchoalveolar lavage cytological pattern in newly diagnosed sarcoidosis
L. Cervis, C. Teleaga, D. Ionita, R. Nemes, N. Basca, E. Crisan, R. Ulmeanu, P. Grigore, M. Alexe, A. Serbescu (Bucharest, Romania)
| |
Is there any clinical application for determining the serum cytokines profile in sarcoid patients?
A. Goljan Geremek, M. Bednarek, U. Demkow, E. Puscinska, M. Czystowska, D. Gorecka (Warsaw, Poland)
| |
The value of magnetic resonance imaging (MRI) with gadolinium as a noninvasive diagnostic method in cardiac sarcoidosis
E. Puscinska, A. Rudnicka, A. Goljan, M. Bednarek, A. Fijalkowska, J. Kober, A. Torbicki, J. Burakowski, W. Tomkowski, M. Jakucinski, D. Piotrowska, L. Krolicki, D. Gorecka (Warsaw, Poland)
| |
Sarcoidosis: depression and negative life events in patients with different course of the disease
V. Vucinic, V. Zugic, S. Filipovic, J. Videnovic, A. Dudvarski (Beograd, Serbia And Montenegro)
| |
An exploration of illness perceptions in sarcoidosis patients
M. Moffat, J. Cleland, Q. Xiaojiu, O. Dempsey (Aberdeen, United Kingdom)
| |
An exploration of coping strategies and quality of life in sarcoidosis patients
M. Moffat, J. Cleland, X. Qi, O. Dempsey (Aberdeen, United Kingdom)
| |
The experience of use plasmaferesis in complex treatment in patients with pulmonary sarcoidosis (PS)
O. Baranova, O. Baklanova, V. Voinov (St. Petersburg, Russian Federation)
| |
Efficiency of pentoxifylline different doses in sarcoidosis treatment
H. Baradzina, I. Kotovich, A. Tahanovich (Minsk, Belarus)
| |
QuantiFERON®-TB or QFT in sarcoidosis
K. A. Khan, M. Uzbeck, A. Collins, V. Twormey, A. O‘Regan (Galway, Ireland)
| |